Study To Assess the Safety and Tolerability of PBF-509 in Male Healthy Volunteers

NCT01691924 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: PBF-509
DRUG: Placebo

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Collaborators

[object Object]